Understanding how COVID-19 affects antibiotic use in hospitals and finding better management strategies.
Characterizing the ImPact of COVID-19 on Antibiotic PreScribing in AcutE Care and IDentifying Resilient Stewardship Strategies (POISED)
This study looks at how the COVID-19 pandemic has changed the way doctors prescribe antibiotics in hospitals, especially when they might not be needed, and it aims to find better ways to use antibiotics safely to protect patients from potential harm and antibiotic resistance.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-10906028 on NIH RePORTER |
What this research studies
This research investigates the impact of the COVID-19 pandemic on antibiotic prescribing practices in acute care settings. It aims to understand how the pandemic has led to increased antibiotic use, even when bacterial infections are not present, and the resulting risks of antibiotic resistance and adverse effects. By analyzing healthcare utilization and delivery changes, the project seeks to develop effective stewardship strategies to optimize antibiotic use and improve patient outcomes during and after the pandemic.
Who could benefit from this research
Good fit: Ideal candidates for this research include hospitalized patients with COVID-19 who may be receiving antibiotics.
Not a fit: Patients who are not hospitalized or do not receive antibiotics during their COVID-19 treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved antibiotic prescribing practices, reducing the risk of antibiotic resistance and enhancing patient safety.
How similar studies have performed: Other research has highlighted the need for improved antibiotic stewardship during the pandemic, indicating that this area is both critical and timely.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Pulia, Michael Santino — University of Wisconsin-Madison
- Study coordinator: Pulia, Michael Santino
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.